Following is a statement by the National Osteoporosis Foundation on the U.S. Food and Drug Administration's Approval of Prolia™

WASHINGTON, DC (June 2, 2010) - Osteoporosis is a serious, widespread and growing public health threat, according to the National Osteoporosis Foundation (NOF). NOF welcomes any new FDA approved treatment options, such as Prolia™, that will help patients address this prevalent disease. NOF estimates 10 million Americans have osteoporosis and another 34 million are at risk for the disease.

To read the FDA announcement regarding Prolia™, please visit www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm214150.htm

About National Osteoporosis Foundation
Established in 1984, the National Osteoporosis Foundation, a leading community-focused health organization, is dedicated to the prevention of osteoporosis and broken bones, the promotion of strong bones for life and the reduction of human suffering through programs of awareness, education, advocacy and research. For more information on the National Osteoporosis Foundation, visit www.nof.org.

# # #

Back to the Press Release Index